Regeneron Pharmaceuticals (NQ: REGN )
1,012.82
-1.77
(-0.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
All News about Regeneron PharmaceuticalsVia Benzinga
FDA Delays Decision For Regeneron's Inaugural Blood Cancer Therapy, Highlights Trial Concerns
March 25, 2024
Via Benzinga
Exposures
Product Safety
Via Benzinga
Via Benzinga
Via GlobeNewswire
The Analyst Verdict: Regeneron Pharmaceuticals In The Eyes Of 10 Experts
February 27, 2024
Via Benzinga
(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest
February 22, 2024
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |